Literature DB >> 1402338

Urinary calcium excretion in essential hypertension.

E W Young1, C D Morris, D A McCarron.   

Abstract

Patients with essential hypertension have been reported to have higher levels of urinary calcium excretion (UCaV) than normotensive persons. We tested the hypothesis that the calciuria of hypertension is due to dietary factors and evaluated several alternate mechanisms. UCaV was studied in 15 patients with essential hypertension compared with 16 age- and gender-matched normotensive control subjects. For subjects taking self-selected, free-living diets, the difference in UCaV between normotensive (130 +/- 14 mg/day) and hypertensive subjects (201 +/- 37 mg/day) was not significant (p = 0.1). However, in a controlled diet with moderately restricted sodium intake (88 mEq), urinary calcium excretion was significantly higher (p = 0.02) in the hypertensive than in the normotensive group receiving 400 mg calcium (204 +/- 25 vs 132 +/- 13 mg/day) and 1400 mg calcium (272 +/- 31 vs 187 +/- 25 mg/day). Twenty-four-hour UCaV was directly and significantly correlated with blood pressure (r = 0.63 for standing systolic blood pressure; p < 0.001). A 1000 mg oral calcium load caused similar changes in UCaV (0.12 +/- 0.11 vs 0.12 +/- 0.07 mg per 100 ml glomerular filtration) and serum ionized calcium level (0.06 +/- 0.08 vs 0.06 +/- 0.02 mmol/L) in normotensive and hypertensive subjects, respectively, suggesting that there was no difference in intestinal calcium absorption between the groups. Fasting UCaV did not differ between the hypertensive (8.9 +/- 4.5 mg per 2 hours) and normotensive groups (10.9 +/- 11.5 mg per 2 hours).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402338

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Authors:  Wonngarm Kittanamongkolchai; Kristin C Mara; Ramila A Mehta; Lisa E Vaughan; Aleksandar Denic; John J Knoedler; Felicity T Enders; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

3.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

Review 4.  The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.

Authors:  Joshua I Barzilay; Barry R Davis; Sara L Pressel; Alokananda Ghosh; Rachel Puttnam; Karen L Margolis; Paul K Whelton
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

5.  Association between hypertension and fragility fracture: a longitudinal study.

Authors:  S Yang; N D Nguyen; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2013-07-27       Impact factor: 4.507

6.  Correlation between Left Ventricular Mass Index and Calcium Metabolism in Patients with Essential Hypertension.

Authors:  Ayşen Helvacı; Besime Copur; Mine Adaş
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

Review 7.  Nephrolithiasis: A Red Flag for Cardiovascular Risk.

Authors:  Alessia Gambaro; Gianmarco Lombardi; Chiara Caletti; Flavio Luciano Ribichini; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

8.  The Risk of Trigeminal Neuralgia Following Osteoporosis.

Authors:  Yu-Feng Su; Chieh-Hsin Wu; Wei-Ting Wang; Ann-Shung Lieu
Journal:  Medicina (Kaunas)       Date:  2022-03-18       Impact factor: 2.430

9.  Relationship between Urinary Calcium Excretion and Lower Urinary Tract Symptoms.

Authors:  Tomohiro Matsuo; Hidenori Ito; Kensuke Mitsunari; Kojiro Ohba; Yasuyoshi Miyata
Journal:  Metabolites       Date:  2022-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.